Misuse may violate federal, provincial, or local laws
Wegovy (semaglutide) is a GLP-1 receptor agonist that slows gastric emptying, potentially exacerbating pre-existing gastric conditions Common gastrointestinal side effects include nausea (44%), vomiting (24%), dyspepsia, abdominal pain, and constipation Gastritis is not listed as a recognised adverse effect in the UK Summary of Product Characteristics Patients with severe gastrointestinal disease or history of peptic ulcer disease should discuss risks with their prescriber before starting treatment Seek urgent medical advice for severe abdominal pain, vomiting blood, black stools, or persistent symptoms that do not improve Table of Contents Can Wegovy Cause Gastritis
doi: 10.1016/j.jsbmb.2021.105844 281 ChengJCFangLYanYHeJGuoYJiaQet al
Melanotan II may benefit individuals who are: Seeking safer tanning without UV overexposure Living with autoimmune or inflammatory disorders Experiencing cravings or metabolic dysregulation Recovering from post-viral or inflammatory states Desiring enhanced libido or sexual performance Side Effects and Considerations Common (Dose-dependent): Nausea (usually transient
N Engl J Med (2013) 368:40715
doi:10.2337/dc24-S015 European Medicines Agency